Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
Flunixin meglumine
GLOBAL VET HEALTH SL
QM01AG90
Flunixin meglumine
50 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Horses, Pigs
flunixin
N.S.A.I.D.
Authorised
2017-12-15
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dugnixon 50 mg/ml solution for injection for cattle, pigs and horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance Flunixin 50.0 mg (Equivalent to flunixin meglumine 82.9 mg) Excipients Phenol 5.0 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Colourless liquid 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses and pigs. 4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE For the control of acute inflammation associated with respiratory disease. The product has also been shown to have some benefit in the treatment of experimental acute bovine pulmonary emphysema (Fog Fever). The product may be used as adjunctive therapy in the treatment of acute mastitis. HORSES For the alleviation of inflammation and pain associated with musculo-skeletal disorders. For the alleviation of visceral pain associated with colic in the horse. PIGS For use as an adjunctive therapy in the treatment of swine respiratory diseases. 4.3. CONTRAINDICATIONS Do not exceed the stated dose or the duration of treatment. Do not use in animals suffering from cardiac, hepatic or renal disease or where there is the possibility of gastro-intestinal ulceration or bleeding. Do not use in known cases of hypersensitivity to flunixin meglumine, other NSAIDs or to any of the excipients. Do not use the product within 48 hours before expected parturition in cows _ _ in such cases an increase in the number of still births has been observed. Do not administer to pregnant mares. Do not administer to pregnant sows, gilts at mating and in breeding boars. Do not use in animals suffering from colic caused by ileus and associated with dehydration. 4.4. SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5. SPECIAL PRECAUTIONS FOR USE. Special precautions for use in animals Avoid intra-arterial injection. NSAIDS are known to have the potential to delay parturition through a tocolytic effect by inhibiting prostaglandins that ar Leggi il documento completo